COMMUNIQUÉS West-GlobeNewswire

DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer
26/07/2018
Montrouge, France, July 26, 2018 DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer Demonstrated track record of success instrumental in preparing for potential Viaskin Peanut launch in [...]
Nomination d'un professionnel reconnu de l'industrie Kevin Trapp au poste de Directeur Commercial de DBV Technologies
26/07/2018
Montrouge, France, le 26 juillet (07H30 CEST), 2018 Nomination d'un professionnel reconnu de l'industrie Kevin Trapp au poste de Directeur Commercial de DBV Technologies Sa grande expérience dans le lancement réussi de [...]
Sanofi Head of Human Resources Roberto Pucci to retire; Company names Caroline Luscombe to take over October 1st
26/07/2018
Sanofi Head of Human Resources Roberto Pucci to retire; Company names Caroline Luscombe to take over October 1 st Paris - July 26, 2018 - Roberto Pucci, Head of Human Resources, will retire from Sanofi after more than 9 [...]
Départ à la retraite de Roberto Pucci, Responsable des Ressources Humaines de Sanofi ; l'entreprise nomme Caroline Luscombe pour lui succéder à compter du 1er octobre
26/07/2018
Départ à la retraite de Roberto Pucci, Responsable des Ressources Humaines de Sanofi ; l'entreprise nomme Caroline Luscombe pour lui succéder à compter du 1 er octobre Paris - Le 26 juillet 2018 - Roberto Pucci, [...]
argenx to host conference call & webcast to report second quarter business update and half year 2018 financial results on August 2, 2018
26/07/2018
Management to host conference call today at 3 p.m. CEST / 9 a.m. EDT July 26, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep [...]
Essilor - News Release: Strong Second Quarter, Delivering on the Growth Strategy
26/07/2018
Strong Second Quarter Delivering on the Growth Strategy PDF version of the news release On track with objectives: First-half like-for-like growth 1 of 4.0%, including 4.8% in Q2, and contribution from operations 2 at 18 [...]
Essilor - Communiqué : Très bon deuxième trimestre, Stratégie de croissance porteuse
26/07/2018
Très bon deuxième trimestre Stratégie de croissance porteuse Version PDF du communiqué S1 en ligne avec les objectifs : croissance en base homogène 1 de 4,0 % (dont 4,8 % au T2) et contribution de l'activité 2 à 18,4 % [...]
Essilor - News Release: Publication of the 2018 Interim Financial Report
26/07/2018
Publication of the 2018 Interim Financial Report PDF version of the news release Charenton-le-Pont, France (July 26, 2018 - 6:30 am) - The Essilor International (Compagnie Générale d'Optique) 2018 Interim Financial [...]
Essilor - Communiqué : Mise à disposition du rapport financier semestriel 2018
26/07/2018
Mise à disposition du rapport financier semestriel 2018 Version PDF du communiqué Charenton-le-Pont, France (le 26 juillet 2018 - 06h30) - Essilor International (Compagnie Générale d'Optique) publie ce matin son rapport [...]
REVA Enters Peripheral Artery Disease Space With First-Ever CE Mark of a Bioresorbale Scaffold for Below the Knee Therapy
26/07/2018
SAN DIEGO, July 25, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, today announced that its MOTIV™ [...]
Telix Pharmaceuticals and JFE Progress Japanese Manufacturing Partnership
26/07/2018
MELBOURNE, Australia and TOKYO, July 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“ Telix ”, the “ Company ”), an Australian biopharmaceutical company focused on the development of diagnostic [...]
R1 RCM to Release Second Quarter 2018 Results on August 9
26/07/2018
CHICAGO, July 25, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it expects to release [...]
Merit Medical Announces Pricing of Public Offering of Common Stock
26/07/2018
SOUTH JORDAN, Utah, July 25, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI) (“ Merit ”), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and [...]
BioCryst Announces Publication of APeX-1 Clinical Trial Results for BCX7353 in The New England Journal of Medicine
26/07/2018
73.8% reduction in attacks with significant benefits in quality of life from once-daily oral dosing of BCX7353 125 mg RESEARCH TRIANGLE PARK, N.C., July 25, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. ( [...]
New Phase 2 Data Analysis for Crenezumab Presented at Global Alzheimer's Conference Provides Strong Evidence for Engagement of the Principle Abeta Target
25/07/2018
Crenezumab significantly reduces Abeta oligomers in cerebrospinal fluid (CSF) in patients with Alzheimer's disease Strong evidence for principal target engagement of Abeta oligomers, the most neurotoxic species of the [...]
MPX Provides Additional and Updated Disclosures in Revised Management’s Discussion and Analysis
25/07/2018
TORONTO, July 25, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE:MPX) (OTC:MPXEF) announced that it has filed today a Revised and Restated Management’s Discussion and Analysis ( [...]
Golden Leaf Holdings Receives State Licensure Approval For Extraction Facility In Portland
25/07/2018
PORTLAND, Ore., July 25, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized [...]
Helix BioPharma Corp. Completes Fourth Dosing Cohort and Initiates Enrollment of the Next Cohort in U.S. Combination Treatment Study of Its Lung Cancer Drug Candidate L-DOS47
25/07/2018
RICHMOND HILL, Ontario, July 25, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP) (FSE:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Myriad Announces Publication of IMPACT Study in Journal of Psychiatric Research
25/07/2018
Results Show that Primary Care Physicians Obtained Improved Outcomes for Patients with Depression When Medication Selection Is Guided by the GeneSight® Test SALT LAKE CITY, July 25, 2018 (GLOBE NEWSWIRE) -- Myriad [...]

Pages